Clinical Trial Detail

NCT ID NCT02920450
Title Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of Florida
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Gedatolisib + Paclitaxel

Age Groups: adult senior

Additional content available in CKB BOOST